JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Right arrow Help viewing high resolution images
Right arrow Return to article
Click on image to view larger version.


Figure 3


FIGURE 3.  (A) BH PET/CT of patient with adenocarcinoma of left lung, with 18F-FDG PET uptake in pulmonary mass (arrows) and SUVmax of 23.3 g/mL, which was 21.2 g/mL on clinical PET/CT. (B and C) Use of BH CT allows detection of carcinomatous lymphangitis adjacent to tumor, characterized by septal thickening (B, arrows), GGOs, and small nodules (C, arrows). (D) It is very hard to depict and characterize the same findings on clinical non-BH CT.





Right arrow Return to article


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE